Behavioral Neurology at Scale: Precision Medicine, and Real-World Implementation*
Date: October 19, 2026
Time: 3:45 pm to 5:15 pm
Room: Coral 2
Track: Traditional Special Interest Group (SIG)
Session Description
Behavioral neurology is entering a new era in which advances in precision medicine, digital phenotyping, artificial intelligence (AI), and scalable care delivery models are transforming how clinicians identify and treat neurologic and neurobehavioral disorders. As patient populations grow and access to specialty care remains limited, there is an urgent need for high-throughput approaches that enhance diagnostic accuracy, personalize treatment selection, and expand the reach of evidence-based interventions across diverse clinical settings.
This session will highlight emerging strategies that leverage multimodal data, biomarkers, AI-enabled analytics, and individualized treatment approaches to optimize outcomes in behavioral neurology. Presentations will emphasize practical implementation in real-world environments, including academic medical centers, community practices, and integrated healthcare systems. Key focus areas include scalable screening and intervention models, measurement-based care, implementation science, and the translation of precision medicine into routine clinical workflows.
The session will also showcase innovative research from junior investigators through selected abstract presentations, fostering interdisciplinary dialogue and highlighting the next generation of advances in the field. By bringing together expertise across clinical care, research, technology, and healthcare delivery, this session aims to define actionable pathways for expanding precision behavioral neurology into scalable, accessible, and patient-centered care models.
Learning Objectives
At the conclusion of this session, attendees will be able to:
- Identify patients appropriate for biomarker-guided evaluation and select candidates for disease-modifying therapies in behavioral neurology.
- Apply evidence-based precision medicine and anti-amyloid treatment strategies in real-world clinical practice.
- Implement scalable strategies for cognitive screening, treatment monitoring, and longitudinal dementia care across diverse healthcare settings.
Speakers
- (Chair) Gregg S. Day, MD, MSc, MSCI
- (Co-Chair) Liliana Ramirez Gomez, MD
- (Speaker) B. Joy Snider, MD, PhD, FANA
- (Speaker) Greg Cooper, MD, PhD
- (Speaker) Armen Moughamian, MD, PhD
Scalable Approaches to Anti-Amyloid Treatment, Monitoring, and Follow-up in Academic Practice
Description
In this presentation, Dr. Snider will discuss how selecting and managing patients on amyloid immunotherapy presents both challenges and opportunities for academic neurology practices. This talk will cover the amyloid immunotherapy experience at Washington University (>600 patients started on therapy), including discussion of patient management, infrastructure needs and how to develop best practices.
Anti-amyloid Treatment in Practice
Description
In this presentation, Dr. Cooper will discuss development, management, and challenges (including reimbursement) of an AAT program in clinical practice.
Deployment of Amyloid-Targeting Therapies Across the Sutter Health System
Description
In this presentation, Dr. Armen will discuss learnings from a non-academic tertiary memory center and how we safely enabled general neurologists to prescribe amyloid targeting therapy.
